HEALTHEQUITY, INC.

(HQY)
  Report
Delayed Nasdaq  -  05/20 04:00:00 pm EDT
59.23 USD   +0.37%
05/16HEALTHEQUITY, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
05/16HealthEquity Sets Date to Announce First Quarter Results
AQ
05/16HealthEquity Releases Annual Corporate Social Responsibility Report
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Buy: Healthequity

12/10/2021 | 06:21am EDT


© MT Newswires 2021
All news about HEALTHEQUITY, INC.
05/16HEALTHEQUITY, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
AQ
05/16HealthEquity Sets Date to Announce First Quarter Results
AQ
05/16HealthEquity Releases Annual Corporate Social Responsibility Report
AQ
05/02HEALTHEQUITY, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, ..
AQ
05/02HealthEquity Expands Board of Directors
AQ
05/02HealthEquity, Inc. Expands Board of Directors
CI
04/11Wells Fargo Starts HealthEquity at Overweight With $95 Price Target
MT
04/07Guggenheim Starts HealthEquity at Buy With $89 Price Target
MT
03/31HEALTHEQUITY, INC. Management's discussion and analysis of financial condition and res..
AQ
03/31NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
More news
Analyst Recommendations on HEALTHEQUITY, INC.
More recommendations
Financials (USD)
Sales 2023 826 M - -
Net income 2023 -53,7 M - -
Net cash 2023 106 M - -
P/E ratio 2023 -93,7x
Yield 2023 -
Capitalization 4 997 M 4 997 M -
EV / Sales 2023 5,92x
Capi. / Sales 2024 5,52x
Nbr of Employees 3 702
Free-Float 98,1%
Chart HEALTHEQUITY, INC.
Duration : Period :
HealthEquity, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HEALTHEQUITY, INC.
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 59,23 $
Average target price 75,92 $
Spread / Average Target 28,2%
EPS Revisions
Managers and Directors
Jon Kessler President, Chief Executive Officer & Director
Tyson Murdock Chief Financial Officer & Executive Vice President
Robert W. Selander Non-Executive Chairman
Elimelech Rosner Chief Technology Officer & Executive VP
Edward Bloomberg Chief Operating Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
HEALTHEQUITY, INC.33.88%4 997
MICROSOFT CORPORATION-24.90%1 888 905
DASSAULT SYSTÈMES SE-26.90%52 874
SYNOPSYS INC.-16.77%46 958
ATLASSIAN CORPORATION PLC-53.47%45 098
SEA LIMITED-64.39%44 589